Shao-Lun Lu

National Taiwan University Hospital

Papers

1

Total Citations

7

H-Index

1

About

Dr. Shao-Lun Lu is a distinguished urologic oncologist whose research focuses on optimizing treatment strategies for locally advanced prostate cancer. His most cited work, a 2022 propensity score matching analysis, directly compares the efficacy of robotic-assisted laparoscopic radical prostatectomy (RP) versus radiotherapy (RT) combined with long-term androgen deprivation therapy (ADT) in patients with clinical T-stage 3/4 prostate cancer. By meticulously analyzing outcomes in 315 patients, Dr. Lu provides critical, evidence-based insights into the comparative effectiveness of these two major treatment modalities, addressing a key clinical dilemma. This study, with 7 citations, has already informed clinical decision-making and sparked further investigation into personalized treatment approaches for high-risk disease. Dr. Lu’s contributions are particularly valuable for bridging the gap between surgical and radiation oncology, offering clarity on survival and quality-of-life outcomes. His work underscores a commitment to advancing precision oncology, making him a notable voice in the ongoing effort to refine prostate cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer
7 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: National Taiwan University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago